脑肿瘤患者电子健康认知康复:一项随机对照试验结果
本研究纳入拟诊低级别胶质瘤和脑膜瘤的成人患者,术前招募,术后3个月随机分入10周平板应用ReMind干预组或等待-list对照组。基于表现的认知结局和患者报告结局在组间均无显著差异,依从性和满意度良好,但招募困难导致统计效能有限。
要点
- 脑肿瘤术后患者对平板认知康复应用ReMind满意度高,90%评价为「好」或「优秀」。
- 干预组与对照组在认知表现、认知抱怨、疲劳及心理困扰上均无显著差异。
- 早期招募困难,56%拒绝者认为参与负担过重,最终样本量有限。
核心结论
- ReMind电子健康认知康复 program 未显示显著疗效,但依从性和满意度良好,临床使用时需根据患者需求调整时机。
研究设计与样本
- 随机对照试验,拟诊低级别胶质瘤和脑膜瘤成人患者术前招募,术后3个月按最小化法分配至10周ReMind干预组或等待-list对照组。
主要发现
- 干预组与对照组的基于表现的认知结局和患者报告结局在组均值随时间变化及可靠变化指数(RCI)上均无显著差异。
- 所有参与者认为平板应用适合用于认知康复交付,90%评价项目为「好」或「优秀」。
- 拒绝参与的患者中56%报告参与负担过重。
临床怎么用
- ReMind可作为脑肿瘤患者认知康复的可接受工具,但需根据患者需求调整干预时机以提升参与度。
局限性
- 早期招募困难导致统计效能有限。
- 最终分析样本量小(干预组20例、对照组25例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence-based cognitive rehabilitation programs for brain tumor patients are not widely available, despite the high need. We aimed to evaluate the effects of a tablet-based cognitive rehabilitation program on cognitive performance, cognitive complaints, fatigue, and psychological distress in primary brain tumor patients following neurosurgery. Also, attrition, adherence and patient satisfaction with the program were evaluated. METHODS: Adults with presumed low-grade glioma and meningioma were recruited before surgery. Three months thereafter, participants were allocated to the intervention group or waiting-list control group using minimization. The 10-week eHealth app ReMind, based on the effective face-to-face intervention, consisted of psychoeducation, strategy-training and attention retraining. Performance-based cognitive outcomes and patient-reported outcomes were assessed before surgery and 3, 6 and 12 months thereafter. Mean scores, percentages of cognitively impaired individuals and reliable change indices (RCIs) were compared between groups. RESULTS: Sixty-two out of 183 eligible patients were randomized. Of the people who declined, 56% reported that participation would to be too burdensome. All participants found a tablet-app suitable for delivery of cognitive rehabilitation and 90% rated the program as "good" or "excellent". Performance-based cognitive outcomes and patient-reported outcomes did not significantly differ in group means over time nor RCIs between the intervention (final n = 20) and control group (final n = 25). CONCLUSIONS: Recruitment at this early stage was difficult, resulting in limited statistical power. No significant effects were demonstrated, while adherence and satisfaction with the eHealth program were good. In clinical practice, ReMind may be helpful, if timing would be adapted to patients' needs.
引用
- van der Linden SD, Rutten GM, Dirven L, et al. eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial. J Neurooncol. 2021. PMID: 34487313. doi:10.1007/s11060-021-03828-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。